HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood
- PMID: 30701532
- DOI: 10.1002/jcp.28219
HIV-1 Tat protein induces aberrant activation of AICDA in human B-lymphocytes from peripheral blood
Abstract
Individuals infected with human immunodeficiency virus (HIV) are at increased risk for Burkitt lymphoma, a B-cell malignancy which occurs after a chromosomal translocation rearranging the MYC oncogene with an immunoglobulin gene locus, usually the IGH heavy chain gene locus. We have previously reported that the HIV protein Tat which circulates in all HIV-positive individuals whatever their immune status caused an increased rate of colocalization between IGH and MYC in B-cells nuclei. We here present in vitro evidence that Tat activates the expression of the AICDA gene that encodes the activation-induced cytidine deaminase whose physiological function is to create double-strand breaks for immunoglobulin gene maturation. In the presence of Tat, DNA damage was observed concomitantly in both MYC and IGH, followed by DNA repair by nonhomologous end joining. AICDA was further found overexpressed in vivo in peripheral blood B-cells from HIV-infected individuals. Thus, the capacity of Tat to spontaneously penetrate B-cells could be sufficient to favor the occurrence of MYC-IGH oncogenic rearrangements during erroneous repair, a plausible cause for the increased incidence of Burkitt lymphoma in the HIV-infected population.
Keywords: B-cell; IGH; activation-induced cytidine deaminase (AID); human immunodeficiency virus-1 (HIV-1) Tat; oncogenesis.
© 2019 Wiley Periodicals, Inc.
References
REFERENCES
-
- Allinne, J., Pichugin, A., Iarovaia, O., Klibi, M., Barat, A., Zlotek-Zlotkiewicz, E., … Vassetzky, Y. S. (2014). Perinucleolar relocalization and nucleolin as crucial events in the transcriptional activation of key genes in mantle cell lymphoma. Blood, 123(13), 2044-2053. https://doi.org/10.1182/blood-2013-06-510511
-
- Chandra, V., Bortnick, A., & Murre, C. (2015). AID targeting: Old mysteries and new challenges. Trends in Immunology, 36, 527-535. https://doi.org/10.1016/j.it.2015.07.003
-
- Clifford, G. M., Polesel, J., Rickenbach, M., Dal maso, L., Keiser, O., Kofler, A., … Franceschi, S. (2005). Cancer risk in the Swiss HIV cohort study: Associations with immunodeficiency, smoking, and highly active antiretroviral therapy. Journal of the National Cancer Institute, 97, 425-432. https://doi.org/10.1093/jnci/dji072
-
- Cobucci, R. N. O., Lima, P. H., de Souza, P. C., Costa, V. V., Cornetta, M., Cornetta, Mda, & Gonçalves, A. K. (2015). Assessing the impact of HAART on the incidence of defining and non-defining AIDS cancers among patients with HIV/AIDS: A systematic review. Journal of Infection and Public Health, 8(1) https://doi.org/10.1016/j.jiph.2014.08.003
-
- Dolcetti, R., Gloghini, A., Caruso, A., & Carbone, A. (2016). A lymphomagenic role for HIV beyond immune suppression? Blood, 127(11), 1403-1409. https://doi.org/10.1182/blood-2015-11-681411
Grants and funding
LinkOut - more resources
Full Text Sources